Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-03-052334
Filing Date
2003-09-22
Accepted
2003-09-22 14:26:54
Documents
6
Period of Report
2003-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 839234
3 LIST OF SUBSIDIARIES dex211.htm EX-21.1 2443
4 CONSENT OF INDEPENDENT AUDITORS dex231.htm EX-23.1 2351
5 CERTIFICATION OF CEO dex311.htm EX-31.1 9080
6 CERTIFICATION OF CFO dex312.htm EX-31.2 9084
7 CERTIFICATION OF CEO & CFO dex32.htm EX-32 4348
  Complete submission text file 0001193125-03-052334.txt   868586
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-26642 | Film No.: 03904017
SIC: 2835 In Vitro & In Vivo Diagnostic Substances